2020 Virtual Mini Symposia Schedule

HomeMembersAssemblies and SectionsAbout2020 Virtual Mini Symposia Schedule ▶ AII - B93 - Late Breaking Clinical Trials In Airway Diseases Mini-Symposia Program
AII - B93 - Late Breaking Clinical Trials In Airway Diseases Mini-Symposia Program

Date: Friday, October 16, 2020

<Back to Mini Symposia Main Page

Moderated By: John Hurst MD, Serpil Erzurum MD, Deepa Rastogi MBBS, MS, ATSF, Laura Crotty Alexander MD, ATSF

  • Vitamin D Supplementation and Severe Disease Exacerbations in Children with Asthma and Low Vitamin D Levels: A Randomized Controlled Trial, Presented by Erick Forno MD, MPH, ATSF (1:00)

  • Ensifentrine Provides Significant and Clinically Meaningful Bronchodilation and Quality of Life Improvement on Top of Tiotropium in Symptomatic COPD Patients in a 4-Week Dose-Ranging Study, Presented by Gary Ferguson MD (13:40)

  • Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) All-Cause Mortality Versus LAMA/LABA in COPD: Sensitivity Analysis of All-Cause Mortality (Secondary Endpoint) in the ETHOS Trial with Final Retrieved Vital Status Data, Presented by Fernando Martinez MD (26:00)

  • Captain Study: Simultaneous Step-Up to High Dose Fluticasone Furoate and Addition of Umeclidinium for the Treatment of Inadequately Controlled Asthma, Presented by Huib Kerstjens MD, PhD (39:45)

  • Efficacy and Safety of Mepolizumab in Hypereosinophilic Syndrome: A Phase III, Randomized, Placebo-Controlled Trial, Presented by Florence Roufosse MD, PhD (55:30)

  • Efficacy and Safety of an Inhaled Anti-TSLP Antibody Fragment in Adults with Mild Atopic Asthma, Presented by Gail Gauvreau PhD, ATSF (1:12:20)

  • Outcomes Following Continuation or Stopping Long-Term Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma: The Randomized Comet Trial, Presented by Wendy C. Moore MD (1:23:45)

  • Masitinib Significantly Decreases the Rate of Asthma Exacerbations in Patients with Severe Asthma Uncontrolled by Oral Corticosteroids: A Phase 3 Multicenter Study, Presented by Pascal Chanez MD, PhD (1:38:00)